2-Pyrrolidone → 1-{5-[4-(4-Chlorobenzoyl)piperidine-1-carbonyl]pyridin-2-yl}pyrrolidin-2-one
Reaction equation
[NH:1]1[CH2:5][CH2:4][CH2:3][C:2]1=[O:6].Br[C:8]1[N:13]=[CH:12][C:11]([C:14]([N:16]2[CH2:21][CH2:20][CH:19]([C:22](=[O:30])[C:23]3[CH:28]=[CH:27][C:26]([Cl:29])=[CH:25][CH:24]=3)[CH2:18][CH2:17]2)=[O:15])=[CH:10][CH:9]=1>>[Cl:29][C:26]1[CH:25]=[CH:24][C:23]([C:22]([CH:19]2[CH2:18][CH2:17][N:16]([C:14]([C:11]3[CH:10]=[CH:9][C:8]([N:1]4[CH2:5][CH2:4][CH2:3][C:2]4=[O:6])=[N:13][CH:12]=3)=[O:15])[CH2:21][CH2:20]2)=[O:30])=[CH:28][CH:27]=1Participants
3
Procedure
Using pyrrolidin-2-one (102 mg) and (6-bromopyridin-3-yl)[4-(4-chlorobenzoyl)piperidin-1-yl]methanone (408 mg) described in Preparation Example 190 and by the reaction and treatment in the same manner as in Example 1, the title compound (209 mg) was obtained.
Workup
- customdescribed in Preparation Example 190 and by the reaction and treatment in the same manner as in Example 1
Sources & evidence
- ORD record
- ord-7865e164fb3a4aba8eef7754b1dfb96a
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…